Skin care brand Cannuka only came to market towards the end of last year, and already the company has received $750,000 in funding and seen 70 percent month-to-month growth in sales.
What’s the secret ingredient behind its success? Cannabis.
The brand’s products consist of a combination of CBD oils and manuka honey.
“CBD...is a very powerful anti-inflammatory...But we knew we needed to complement that with another ingredient,” explained Cannuka's Founder and CEO, Michael Bumgarner. “That’s when we found manuka honey, [which] is the most powerful antibacterial honey in the world.”
On top of the ingredients, Cannuka’s branding was designed to appeal to a wider market.
“We knew because we’re in the cannabis space we had to be approachable,” said Bumgarner. “It’s harder to explain the benefits because you have that stigma still about it.”
So far, Cannuka has been selling direct-to-consumer through its website but now wants to hit brick-and-mortar stores.
For the full interview, [click here](https://cheddar.com/videos/inside-the-power-of-cbd-for-skincare).
A historic wave of IPOs is about to hit Wall Street. For the average investor watching from the sidelines, the frenzy can engender fears of missing out.
Applied Aerospace & Defense CEO Trip Ferguson discusses the company's IPO, defense spending, space innovation, and the future of U.S. aerospace manufacturing.
David Fahrenthold, investigative reporter for The New York Times, examines rising costs, contracts, and transparency concerns in Trump's D.C. projects.
